Up to Half of HIV-Infected Patients on Effective HAART Still Ultimately Develop Neurocognitive Impairment, Study Finds (February 11, 2009)
Igor Grant, M.D., presents new data from the CHARTER study indicating that, although the prevalence of dementia is significantly down in the modern treatment era, 40 percent to 50 percent of HIV-infected patients on effective HAART will still eventually develop some form of neurological impairment -- and in most cases, the impairment will impact their day-to-day lives.
In The 16th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO
The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.